Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Oropharyngeal cancers: relationship between epidermal growth factor receptor alterations and human papillomavirus status.

Mirghani H, Amen F, Moreau F, Guigay J, Hartl DM, Lacau St Guily J.

Eur J Cancer. 2014 Apr;50(6):1100-11. doi: 10.1016/j.ejca.2013.12.018. Epub 2014 Jan 11. Review.

PMID:
24424107
2.

Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma.

Perrone F, Suardi S, Pastore E, Casieri P, Orsenigo M, Caramuta S, Dagrada G, Losa M, Licitra L, Bossi P, Staurengo S, Oggionni M, Locati L, Cantu G, Squadrelli M, Carbone A, Pierotti MA, Pilotti S.

Clin Cancer Res. 2006 Nov 15;12(22):6643-51. Erratum in: Clin Cancer Res. 2007 Jul 15;13(14):4313.

3.

The role of the human papillomavirus in oropharyngeal cancer.

Naidu A, Wright JM.

Tex Dent J. 2011 May;128(5):447-54. Review.

PMID:
21834367
4.

The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer.

Shaw R, Robinson M.

Br J Oral Maxillofac Surg. 2011 Sep;49(6):423-9. doi: 10.1016/j.bjoms.2010.06.023. Epub 2010 Aug 19. Review.

PMID:
20727631
5.

Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area.

Al-Swiahb JN, Huang CC, Fang FM, Chuang HC, Huang HY, Luo SD, Chen CH, Chen CM, Chien CY.

Arch Otolaryngol Head Neck Surg. 2010 May;136(5):502-8. doi: 10.1001/archoto.2010.47.

PMID:
20479383
6.

[HPV infection in head and neck squamous cell carcinoma (HNSCC). Highlights from ASCO 2010].

Ihloff AS, Knecht R, Tribius S.

HNO. 2010 Dec;58(12):1163-7. doi: 10.1007/s00106-010-2200-0. Review. German.

PMID:
20963389
7.

EGFR mutations and human papillomavirus in lung cancer.

Kato T, Koriyama C, Khan N, Samukawa T, Yanagi M, Hamada T, Yokomakura N, Otsuka T, Inoue H, Sato M, Natsugoe S, Akiba S.

Lung Cancer. 2012 Nov;78(2):144-7. doi: 10.1016/j.lungcan.2012.08.011. Epub 2012 Sep 10.

PMID:
22975156
8.

De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials.

Masterson L, Moualed D, Liu ZW, Howard JE, Dwivedi RC, Tysome JR, Benson R, Sterling JC, Sudhoff H, Jani P, Goon PK.

Eur J Cancer. 2014 Oct;50(15):2636-48. doi: 10.1016/j.ejca.2014.07.001. Epub 2014 Aug 1. Review.

PMID:
25091798
9.

HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas.

Kostareli E, Holzinger D, Bogatyrova O, Hielscher T, Wichmann G, Keck M, Lahrmann B, Grabe N, Flechtenmacher C, Schmidt CR, Seiwert T, Dyckhoff G, Dietz A, Höfler D, Pawlita M, Benner A, Bosch FX, Plinkert P, Plass C, Weichenhan D, Hess J.

J Clin Invest. 2013 Jun;123(6):2488-501. doi: 10.1172/JCI67010. Epub 2013 May 1.

10.

Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.

Fei J, Hong A, Dobbins TA, Jones D, Lee CS, Loo C, Al-Ghamdi M, Harnett GB, Clark J, O'Brien CJ, Rose B.

Ann Surg Oncol. 2009 Oct;16(10):2908-17. doi: 10.1245/s10434-009-0579-1. Epub 2009 Jul 15.

PMID:
19603236
11.

Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma.

Cortelazzi B, Verderio P, Ciniselli CM, Pizzamiglio S, Bossi P, Gloghini A, Gualeni AV, Volpi CC, Locati L, Pierotti MA, Licitra L, Pilotti S, Perrone F.

J Oral Pathol Med. 2015 Oct;44(9):734-45. doi: 10.1111/jop.12301. Epub 2014 Dec 14.

PMID:
25495427
12.

The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck.

Psyrri A, Rampias T, Vermorken JB.

Ann Oncol. 2014 Nov;25(11):2101-15. doi: 10.1093/annonc/mdu265. Epub 2014 Jul 23. Review.

PMID:
25057165
13.

Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.

Woodworth CD, Diefendorf LP, Jette DF, Mohammed A, Moses MA, Searleman SA, Stevens DA, Wilton KM, Mondal S.

Virology. 2011 Dec 5;421(1):19-27. doi: 10.1016/j.virol.2011.09.014. Epub 2011 Oct 5.

14.

Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.

Klussmann JP, Mooren JJ, Lehnen M, Claessen SM, Stenner M, Huebbers CU, Weissenborn SJ, Wedemeyer I, Preuss SF, Straetmans JM, Manni JJ, Hopman AH, Speel EJ.

Clin Cancer Res. 2009 Mar 1;15(5):1779-86. doi: 10.1158/1078-0432.CCR-08-1463. Epub 2009 Feb 17.

15.

p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx.

Perrone F, Mariani L, Pastore E, Orsenigo M, Suardi S, Marcomini B, DaRiva L, Licitra L, Carbone A, Pierotti MA, Pilotti S.

Cancer. 2007 Jun 15;109(12):2461-5.

16.

Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas.

Biron VL, Mohamed A, Hendzel MJ, Alan Underhill D, Seikaly H.

J Otolaryngol Head Neck Surg. 2012 Apr;41 Suppl 1:S65-70.

PMID:
22569052
17.

Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.

Young RJ, Rischin D, Fisher R, McArthur GA, Fox SB, Peters LJ, Corry J, Lim A, Waldeck K, Solomon B.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1230-7. doi: 10.1158/1055-9965.EPI-10-1262. Epub 2011 Apr 5.

18.

Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.

Weinberger PM, Yu Z, Kountourakis P, Sasaki C, Haffty BG, Kowalski D, Merkley MA, Rimm DL, Camp RL, Psyrri A.

Otolaryngol Head Neck Surg. 2009 Sep;141(3):382-9. doi: 10.1016/j.otohns.2009.04.014.

PMID:
19716018
19.

Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer.

Hong A, Dobbins T, Lee CS, Jones D, Jackson E, Clark J, Armstrong B, Harnett G, Milross C, O'Brien C, Rose B.

Eur J Cancer. 2010 Jul;46(11):2088-96. doi: 10.1016/j.ejca.2010.04.016. Epub 2010 May 25.

PMID:
20537890
20.

Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.

Uribe P, Gonzalez S.

Pathol Res Pract. 2011 Jun 15;207(6):337-42. doi: 10.1016/j.prp.2011.03.002. Epub 2011 Apr 29. Review.

PMID:
21531084

Supplemental Content

Support Center